Tilray Brands (TLRY) Free Cash Flow (2017 - 2026)
Tilray Brands' (TLRY) quarterly Free Cash Flow came in at -$37.3 million in Q2 2026, down 95.03% YoY from -$750.3 million in Q2 2025, and down 70.1% on a QoQ basis from -$21.9 million in Q1 2026.
Tilray Brands (TLRY) Free Cash Flow (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Free Cash Flow data on file, last reported at -$37.3 million in Q2 2026.
- Quarterly Free Cash Flow fell 95.03% year-over-year to -$37.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$69.1 million (up 45.78% YoY) and the FY2026 annual result came in at -$69.1 million, up 45.78% from the prior year.
- Free Cash Flow slipped to -$37.3 million in Q2 2026, from -$21.9 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $31.2 million in Q2 2023 to a low of -$51.0 million in Q1 2022.
- A 5-year average of -$19.3 million and a median of -$21.1 million in 2025 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow slumped 890.02% — and 2023, when it jumped 219.43%.
- Tracing TLRY's Free Cash Flow over 5 years: stood at $24.7 million in 2022, then tumbled by 247.0% to -$36.3 million in 2023, then decreased by 27.27% to -$46.2 million in 2024, then surged by 81.51% to -$8.5 million in 2025, then plunged by 337.2% to -$37.3 million in 2026.
- The last three Free Cash Flow figures came in at -$37.3 million (Q2 2026), -$21.9 million (Q1 2026), and -$8.5 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Tilray Brands | 513.31 Mn | 278.68 Mn | 90.52 Mn | -47.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -37.32 Mn |
| May 31, 2026 | -37.32 Mn |
| Feb 28, 2026 | -21.94 Mn |
| Feb 28, 2026 | -21.94 Mn |
| Nov 30, 2025 | -8.54 Mn |
| Nov 30, 2025 | -8.54 Mn |
| Aug 31, 2025 | -1.34 Mn |
| Aug 31, 2025 | -1.34 Mn |
| May 31, 2025 | -19.14 Mn |
| May 31, 2025 | -19.14 Mn |
| Feb 28, 2025 | -20.18 Mn |
| Feb 28, 2025 | -20.18 Mn |
| Nov 30, 2024 | -46.16 Mn |
| Nov 30, 2024 | -46.16 Mn |
| Aug 31, 2024 | -42.04 Mn |
| Aug 31, 2024 | -42.04 Mn |
| May 31, 2024 | 21.00 Mn |
| May 31, 2024 | 21.00 Mn |
| Feb 29, 2024 | -24.89 Mn |
| Feb 29, 2024 | -24.89 Mn |